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Background. Carcinosarcoma of the lung is a rare malignant neoplasm. We evaluated the diagnosis and treatment of six
carcinosarcoma cases, including a synchronous tumour and a solitary pulmonary tumour, along with the clinical and histological
features and survival times. Methods. From a retrospective analysis of 1076 non-small-cell lung cancer resections performed
between January 1996 and January 2011, six patients (0.5%) with pulmonary carcinosarcoma (all males; mean age 58 years; range
53–66) who underwent surgical treatment were studied. Results. The mean tumour pathological T diameter was 7.2cm (median
6cm,range3–14.5cm).Onlyonepatientwasdiagnosedwithcarcinosarcomapreoperatively.Theclinicalpresentationandtumour
localisations diﬀered. The operations performed were a lobectomy (n = 4), pneumonectomy (n = 1), and bilobectomy (n = 1).
Histologically,theepithelialcharacteristicsofthetumourswereconsistentwithsquamouscellcarcinomainmostofthepatients.A
complete resection was performed in all six patients. No mortality occurred in the early postoperative period. The median survival
timewas9(3–25)months.Conclusion.Thepreoperativediagnosisofcarcinosarcomaofthelungisdiﬃcultduetothecomposition
of the diﬀerent histopathological structures. Complete surgical resection is the treatment of choice for pulmonary carcinosarcoma,
although further studies are needed.
1.Introduction
Pulmonary carcinosarcoma (PCS) is a rare tumour in hu-
mans [1, 2]. It was ﬁrst deﬁned by Kika et al. in 1908 as
ap o o r l yd i ﬀerentiated non-small-cell carcinoma containing
a component with sarcoma or sarcoma-like features [3]. It
accounts for 0.3 to 1% of all pulmonary cancers, and its
clinicalcharacteristics,preoperativediagnosticmethods,and
prognostic factors are still not completely understood [4].
Pulmonary carcinosarcomas occur predominantly in elderly
men and middle-aged smokers [5]. This study evaluated the
results of six cases who underwent surgery for PCS.
2.MaterialandMethod
This was a retrospective study of six patients who underwent
surgery for pulmonary tumours in our chest surgery clinic
betweenJanuary1996 andJanuary2011 andwhohadapost-
operative diagnosis of PCS. The patients were evaluated in
terms of their age, gender, symptoms, diagnostic approaches,
surgical methods, and followup ﬁndings.
All of the patients underwent routine laboratory studies,
respiratory function tests, electrocardiography, chest X-ray,
computed tomography (CT) of the thorax, brain CT or
magnetic resonance imaging (MRI), abdominal ultrasound,2 The Scientiﬁc World Journal
Table 1: Characteristics of the patients.
Patient Age Cigar (pack
years) Symptoms Endobronchial
Component Localization Diameter (cm)
CT/surgical
Preoperative
diagnosis
16 3 9 0 Cough
hemoptysis Yes Right lower lobe 3/3 NSCLC
(epidermoid)
26 6 4 0
Chest pain,
Hemoptysis
Cough
Yes Right central 8/10
NSCLC with
neuroendocrine
diﬀerantiation
35 4 6 0
Hemoptysis
Chest pain
Cough
No
Right hiler
intermediate
Bronch
5/6,5 Carcinosarcoma
45 3 5 0
Hemoptysis
Chest pain
Cough
No Left lower lobe 10/14,5 NSCLC
5 55 30 — No Left upper lobe 3/3,7 None
65 6 4 0 Chest pain
Dyspnea No Left lower lobe 3,7/5,5 NSCLC
NSCLC: Non-small-cell lung carcinoma.
Figure 1: Chest X-ray of a patient showing a mass lesion located left hiler localization.
and bronchoscopy. Three patients underwent positron emis-
sion tomography (PET)-CT. In the preoperative period,
one patient without a cancer diagnosis was suspected of
having lung cancer, and one patient had a diagnosis of
carcinosarcoma, whereas the other four patients were di-
agnosed with non-small-cell lung cancer (NSCLC). The
patient who had a preoperative diagnosis of carcinosarcoma
had an endobronchial component and was diagnosed by
bronchoscopy. The mediastinal lymph nodes were evaluated
by mediastinoscopy in all but one patient. A standard pos-
terolateral thoracotomy incision and intraoperative staging
were done in all patients. Complete resection was done in
all patients. All of the tumours were staged postoperatively
according to the seventh international TNM staging system.
The diagnosis was veriﬁed immunohistochemically.
All patients underwent clinical and radiological follow-
upforamedianof7.5(range3–25)months.Allpatientswere
assessed quarterly for the ﬁrst 2 years with a history, physical
examination, and chest X-ray. Laboratory tests and advanced
radiological methods were requested if there were any symp-
toms. Additionally, all patients or the families were asked by
phone when the study was performed and asked about any
signs of recurrence or complications.
The statistical analysis was done using SPSS ver. 11.5.
Descriptive analysesand Kaplan-Meiersurvival analysiswere
used.
3. Results
All six patients were male and heavy smokers (mean 52
packs/year (median 45, range 30–90)), with a median age
of 56 (range 53–66) years. The most common presenting
symptom was cough (Table 1).
Two of the tumours were located peripherally, three were
locatedcentrally(Figure 1),andthesixthhadcomponentsin
bothareas.Thediagnosiswasmadebyﬁne-needleaspiration
biopsy in two patients and by ﬁbre optic bronchoscopy in
three patients. Three of the six patients underwent PET-
CT. In these patients, pathological uptake was detected in
the tumours, but no mediastinal involvement was detected.
The operations performed were a pneumonectomy (due toThe Scientiﬁc World Journal 3
Table 2: Diagnostic characteristics of the lesions.
Patient TNM Stage Cellular components
of end diagnosis Resection Followup
time (m) Prognosis
1 T3N0M0 IIB Squamous
Chondrosarcoma
Right Lower
lobectomy 10 Death
2 T3 N1M0 IIIA Squamous
Osteosarcoma
Right extrapleural
Pneumonectomy 9 Death
3 T3N1M0 IIIA Squamous
Spindle cell
Right lower sleeve
bilobectomy 25 Alive
4 T3N0M0 IIB Adenocarcinoma
Osteosarcoma
Left lower
lobectomy 5 Death
5 T2AN0M0 IB Adenocarcinoma
Chondrosarcoma
Left upper
lobectomy 6A l i v e
6 T2BNOMO IIA Squamous
Osteosarcoma
Left lober
lowectomy 3 Death
(a) (b)
(c)
Figure 2: (a) Showing both squamous cell carcinoma and osteosarcoma seen in the same pies (×40 H&E). (b) With bigger magniﬁcation
squamous cell carcinoma (×400 H&E). (c) Osteosarcoma components from the same pies (×400 H&E).
ﬁssure invasion) in one patient, bilobectomy in another, and
lobectomy in the others (Table 2).
Histologically, the epithelial characteristics of the
t u m o u r sw e r ec o n s i s t e n tw i t hs q u a m o u sc e l lc a r c i n o m a
(n = 4) and adenocarcinoma (n = 2). The sarcomatous
component was mostly chondrosarcomatous type and
osteosarcomatous type (Table 2, Figure 2). No mortality
occurred in the early postoperative period, although a
bronchopleural ﬁstula (BPF) developed in two patients in
the ﬁrst postoperative month. A right lower bilobectomy was
done in one of these patients, and the BPF was treated with a
complementary pneumonectomy and omentoplasty. In the
other patient, a right pneumonectomy was done to treat the
tumour invasion of the ﬁssure, and the BPF was treated with
an omentoplasty.
All of the patients were sent for oncological evaluations,
and two patients with N1 disease received chemotherapy;
chemotherapy was not deemed necessary for the others. In4 The Scientiﬁc World Journal
one patient, a synchronous squamous cell carcinoma (stage
IA) was also detected. This patient refused further treatment
after one dose of chemotherapy.
One of the patients died from brain metastasis at 10
months, and three other patients died of local metastases at
3, 5, and 9 months, respectively. Only two of the six patients
werealiveatthetimeofevaluation.Themediansurvivaltime
was 9 months (95% CI 1,16–16,84; range 3–25).
4. Discussion
Pulmonary carcinosarcoma is a subgroup of pulmonary
sarcomatoid carcinomas. Currently, pulmonary sarcomatoid
carcinomas are deﬁned as poorly diﬀerentiated non-small-
cell carcinomas containing a component with sarcoma or
sarcoma-like (spindle or giant cell) features. Its deﬁnition
was ambiguous until the recent establishment of World
Health Organisation (WHO) criteria, which classify it into
carcinosarcoma, pleomorphic carcinoma, and spindle cell
carcinoma [6].
Pulmonary carcinosarcoma is more common among
males with a smoking history. The literature reports a 4-
to 7.25-fold male dominance [7–9]. In our group, all of the
patients were male, with a mean age of 58 years, and all were
heavy cigarette smokers, as expected.
The gross pathology of the tumour was either an
intraparenchymal or intrabronchial polypoid mass. Koss et
al. reported central localisation in 62% of cases [5]. The
clinical presentation of the centrally localised type involves a
cough, dyspnoea, and haemoptysis, like other endobronchial
tumours. The second type of PCS, the peripheral solid
parenchymal type, often presents as a large mass. These
tumours are asymptomatic in the early stage, during which
time they may involve the adjacent organs or structures
such as the mediastinum, pleura, and thoracic wall [10].
Moore reported that one-third of these tumours were
located peripherally [11], whereas Yazıcı et al. reported a
peripheral location in 85.7% [12]. In our series, 66% of the
patients had peripheral tumours, and their symptoms were
consistent with the literature. Interestingly, one presented
with a solitary pulmonary nodule. Although the reported
radiological properties of these tumours in the English
literature do not include solitary pulmonary nodule, this can
also be a presentation of PCS.
In three of the six patients, PET-CT was performed.
Two patients had positive uptake, and the other case was
borderline. Only one paper about mean positron emission
tomography uptake was published in the English language
literature and it found that uptake of sarcomatoid carcinoma
is signiﬁcantly higher than in other types of lung cancer (P<
0.0001) [13]. No other information on the PET-CT ﬁndings
of PCS of the lung has been reported, and the ﬁndings in our
series were variable.
In our cases, the mean tumour diameter was 7.2cm,
which concurs with the literature. Our series had lower-
lobe dominance in contrast to the reported upper-lobe
dominance [5, 10, 11].
Immunohistochemical techniques are used to diﬀeren-
tiate the epithelial and mesenchymal tumour elements of
carcinosarcomas. The carcinomatous component is non-
small-cell lung carcinoma, including squamous cell car-
cinoma, adenocarcinoma, and large-cell carcinoma. The
most common epithelial component is squamous cell car-
cinoma. Takeda et al. reported a rate of 69% for squamous
cell carcinoma, 24% for adenocarcinoma, and 6% for a
combination of carcinomas [8]. Koss et al. reported that
the most frequent epithelial component was squamous cell
carcinoma (46%), followed by adenocarcinomas (31%) and
adenosquamous cell carcinoma (19%) [5]. Similarly, in
67% of our cases, the epithelioid component was squa-
mous cell carcinoma, and it was adenocarcinoma in 33%.
The sarcomatous component involves poorly diﬀerentiated
osteosarcoma, chondrosarcoma, or rhabdomyosarcoma [5,
7, 8]. In our cases, osteosarcoma, chondrosarcoma, and
spindle cell carcinoma were mostly seen in the sarcomatous
component.
Interestingly,oneofourcaseshadasynchronoustumour
at the time of diagnosis. The pathological diagnosis of one of
these two tumours was carcinosarcoma, whereas the other
one was a stage Ia (T1N0M0) squamous cell carcinoma
located in the other lobe, without involvement of the
shared lymph nodes. Synchronous tumours are rare [14],
and synchronous tumours in which one component is car-
cinosarcoma are rarer, with no other case reported in the
English-language literature.
Complete surgical removal of the tumour with negative
tumour margins constitutes the desired treatment approach.
There is limited information on systemic treatment options
such as chemotherapy and radiotherapy [15, 16]. Neverthe-
less, the aggressive nature and poor diﬀerentiation of this
tumour render the treatment diﬃc u l ta n dr e s u l ti nap o o r
prognosis [17]. Although relatively satisfying survival rates
have been reported in some series (49.3% by Petrov et al. and
57% by Yazici et al.), the survival was poor in others (21.3%
in Koss et al.) [5, 12, 18]. In a most recent series involving
sarcomatoid carcinoma reported by Park et al., survival rates
have been reported as 54.3% and mean followup was 16.07
months [13]. In our series, the median survival time was 9
months.
Although complete resection was performed on all of
our tumours, the survival time was short, as in Koss et
al. [5]. Fishback et al. reported that a tumour diameter
larger than 5cm, disease stage higher than stage I, and the
presence of lymph node involvement had negative eﬀects on
the prognosis [4, 19].
In most cases, the preoperative diagnosis is incomplete,
and lung resection is needed for a deﬁnite diagnosis. The
complete, correct diagnosis in ﬁve of our six cases could not
be made before resection. Although local metastases after
complete surgical resection are rare in NSCLC, we recorded
local metastases in two of the PCS cases. We explained this
as due to the aggressive local behaviour of the tumour, as did
Sato et al. [20].
Metastasis is frequent and is most common to the lymph
nodes, followed by the kidneys, bones, liver, and brain [5].
One of our cases died of brain metastasis at 10 months.
In conclusion, a preoperative diagnosis of carcinosar-
coma of the lung is diﬃcult due to the composition ofThe Scientiﬁc World Journal 5
the diﬀerent histopathological structures. This tumour can
present as a solitary pulmonary nodule or as a component of
synchronous tumours. Unlike reports in the literature, it can
alsoinvolvethelowerlobe.Completesurgicalresectionisstill
the only eﬀective treatment for pulmonary carcinosarcoma,
but the prognosis is poor. The clinical and prognostic
properties of carcinosarcomas are still unknown, and more
studies and larger multicentric series are needed.
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